Global Regulatory Expertise Lachman Consultants offers extensive regulatory strategy, inspection readiness, and compliance services across FDA, EMA, HPRA, and MHRA, presenting a broad cross-border sales opportunity for clients seeking end-to-end regulatory support and international submissions.

Product Lifecycle Focus With capabilities in quality assurance, systems evaluation, data integrity, and regulatory affairs, there is a strong upsell path to clients needing integrated solutions from development through submission and post-market compliance.

Therapeutic Sector Reach Serving pharmaceuticals, biologics, medical devices, and combination products, Lachman can target diverse segments currently pursuing regulatory readiness, quality improvements, or AI-driven compliance enhancements.

Thought Leadership & Events Active participation in industry conferences (TIDES, PDA Week, Global Pharmaceutical Quality Summit, CPhI) indicates opportunities for speaking engagements, sponsored sessions, and targeted outreach to attendees seeking regulatory strategy and inspection readiness services.

Growth Signals & Scale Revenue range and mid-size employee base suggest feasibility for scalable service packages, retainer-based engagements, and tiered offerings to expand footprint within existing clients and attract similar mid-market pharma, biotech, and device companies.